QuVa Pharma Acquires LogicStream Health
25 Jul 2024 //
PR NEWSWIRE
PANTHERx Partners With ITF Therapeutics For DUVYZAT Distribution
25 Jul 2024 //
PR NEWSWIRE
US FDA approves Italfarmaco`s drug for Duchenne muscle-wasting disorder
22 Mar 2024 //
REUTERS
FDA Approves Nonsteroidal Treatment for Duchenne Muscular Dystrophy
21 Mar 2024 //
PR NEWSWIRE
Results from Italfarmaco Pivotal Phase 3 EPIDYS Study of Givinostat in DMD
19 Mar 2024 //
BUSINESSWIRE
Italfarmaco Group Receives EMA Validation of MAA for Givinostat
05 Sep 2023 //
BUSINESSWIRE
Italfarmaco Completes FDA Submission of NDA for Givinostat in DMD
29 Jun 2023 //
BUSINESSWIRE